Food And Drug Administration - Catalysis

Relevant Publications

Quantification of treprostinil concentration in rat and human using a novel validated and rapid liquid chromatography-tandem mass spectrometry method: Experimental and clinical applications in ischemia-reperfusion injury.

Issue Release: 2024

Inflammatory myofibroblastic tumor from molecular diagnostics to current treatment.

Issue Release: 2024

Anti-amyloid-β Antibodies and Anti-tau Therapies for Alzheimer\'s Disease: Recent Advances and Perspectives.

Issue Release: 2024

Cancer treatment with biosimilar drugs: A review.

Issue Release: 2024

L-theanine alleviates myocardial ischemia/reperfusion injury by suppressing oxidative stress and apoptosis through activation of the JAK2/STAT3 pathway in mice.

Issue Release: 2024

Comparative analysis of adverse events among intravesical drugs in bladder cancer: a real-world study on FAERS database.

Issue Release: 2024

Quantification of the Plasma Concentration of Vadadustat by High-Performance Liquid Chromatography with Ultraviolet Detection and Ultra-Performance Liquid Chromatography-Tandem Mass Spectrometry.

Issue Release: 2024

A Long-Term Safety and Tolerability Study of TV-46000 for Subcutaneous Use in Patients with Schizophrenia: A Phase 3, Randomized, Double-Blinded Clinical Trial.

Issue Release: 2024

Pharmacotherapeutic options for metabolic dysfunction-associated steatotic liver disease: where are we today?

Issue Release: 2024

WHO and United States Food and Drug Administration extend the CRP-Lite pilot.

Issue Release: 2024

Whiteness and greenness assessments of a sensitive HPLC method with fluorimetric detection for dapagliflozin quantitation in human plasma: Application to a healthy human volunteer.

Issue Release: 2024

Clarifications on the Intended Use of USP <61> Microbiological Examination of Nonsterile Products: Microbial Enumeration Tests.

Issue Release: 2024

Differences Between the 2016 and 2022 Food and Drug Administration Guidance-Implications for Design and Interpretation of Clinical Trials in Ulcerative Colitis.

Issue Release: 2024

Determination of procoagulant activity in human normal immunoglobulin preparations for therapeutic use by FXIa chromogenic assay: Evaluation of test kit sensitivity, reference standard performance and product formulation effects on the FXIa assay.

Issue Release: 2024

Real-world outcomes of combined lenvatinib and anti-PD-1 in advanced melanoma: the Lenvamel study, a multicenter retrospective study of the French Group of Skin Cancers (Groupe de Cancérologie Cutanée).

Issue Release: 2024

Drug-coated balloons for coronary artery disease: An updated review with future perspectives.

Issue Release: 2024

A CD36-dependent non-canonical lipid metabolism program promotes immune escape and resistance to hypomethylating agent therapy in AML.

Issue Release: 2024

Poly (ADP-ribose) polymerase (PARP) inhibitors as anticancer agents: An outlook on clinical progress, synthetic strategies, biological activity, and structure-activity relationship.

Issue Release: 2024

Overdosage Section in US and EU Labeling.

Issue Release: 2024

Investigation into the genotoxic impurity, 1-methyl-4-nitrosopiperazine, in rifampicin.

Issue Release: 2024

What Impact Do Organic Letters Have on Industrial Applications?

What role do standard operating procedures (SOPs) play in safety?

What Are Some Successful Examples?

Why is Scaling Important?

What are Single Component Gases?

What is the European Federation of Catalysis Societies (EFCATS)?

What are the Challenges in Catalysis for Energy Applications?

How Does Leakage Affect Catalytic Processes?

What are the Advantages of Using Biometric Systems in Catalysis?

Why is Operational Downtime Critical?

Food And Drug Administration - Catalysis

Relevant Publications

Partnered Content Networks

Relevant Topics